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Extraosseous Ewing’s sarcoma/peripheral neuroectodermal tumors (ES/PNETs) are
rare neoplasms that account for approximately 10%-15% of soft tissue sarcomas
in children and 5% of soft tissue sarcomas in adults. Primary spinal, extraosseous,
intradural ES/PNETs are even less common. The diagnosis of ES/PNET is extremely
challenging, because the tumor can have a nonspecific radiologic appearance, and
the histologic features are shared by many other “small round cell tumors.” Thus,
ES/PNET should be included in the radiologic and pathologic differential diagnosis,
even in older patients and in unusual tumor sites. We report two cases of spinal,
extraosseous, intradural ES/PNETs in adults who presented with back pain. Magnetic
resonance imaging revealed contrast enhancing, intradural lesions in the area of
the conus medullaris. The tumor in Case 1 was partially intramedullary, while the
tumor in Case 2 was exclusively extramedullary. In both cases, the radiologic and
intraoperative surgical impression favored ependymoma. The diagnosis of ES/
PNET was established in both cases by histopathologic, immunohistochemical,
and molecular analysis.
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INTRODUCTION
Ewing’s sarcoma/peripheral neuroectodermal tumor (ES/
PNET) is a highly malignant primitive neoplasm, occurring
most commonly as a primary tumor of bone in children
and young adults.[1] When ES/PNET affects older patients,
the tumor most often presents as an extraosseous soft
tissue mass.[2]
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ES/PNET is a member of a group of heterogenous
mesenchymal tumors with round cell morphology
designated “small round cell sarcomas,” which includes
alveolar rhabdomyosarcoma, desmoplastic small round
cell tumor, mesenchymal chondrosarcoma, and poorly
differentiated synovial sarcoma. [3] Other tumors that
may have a similar “small round cell” appearance include
lymphoma, Merkel cell carcinoma, small cell carcinoma,
and Wilms’ tumor. A precise diagnosis is critical, as the
management of ES/PNET differs dramatically from the other
histologically similar neoplasms.
We present two cases of ES/PNET occurring in the spinal,
intradural location. A small number of cases of ES/PNET
have been reported in this unusual location.[4] Case 1 was
a 26‑year‑old male with a recent history of back pain.
Case 2 was a 70‑year‑old male with increasing back pain
and a history of multiple tumors. The tumor in Case 1 was
shown by radiologic and intraoperative examination to
be intramedullary, an extremely rare occurrence, while
the tumor in Case 2 was extramedullary. These two cases
highlight the importance of considering ES/PNET in the
radiologic differential for intradural spinal tumors.

There was no signal abnormality in the adjacent spinal
cord or syringomyelia. There was no evidence of secondary
lesion or leptomeningeal enhancement in the brain,
thoracic and upper cervical spine. Ependymoma was
the most probable diagnosis, but in view of the patient’s
history of malignancy, the possibility of metastasis was
also considered. Although the patient had a history of
schwannoma in the upper extremity, this diagnosis was
considered less likely.

PATHOLOGIC FEATURES
The intraoperative impression in Case 1 was that the
mass was grossly consistent with ependymoma. The
tumor was noted to have both an intramedullary and
an extramedullary component. The extramedullary
portion of the tumor was completely resected first, and

RADIOLOGIC FEATURES
A 26‑year‑old male (Case 1) presented with new onset
of low back pain without antecedent injury. Magnetic
resonance imaging (MRI) of the lumbar spine showed
a 4.1 × 1.6 cm, T1 hypointense, and T2 hyperintense,
intradural mass lesion at T12‑L1, arising from the area of
the conus medullaris and extending inferiorly. The lesion
was densely invested with the roots of the cauda equina
and demonstrated heterogeneous enhancement [Figure 1].
There was no evidence of hemorrhage, peritumoral
edema, or syringomyelia. Imaging of the entire central
nervous system showed no evidence of leptomeningeal
enhancement or cerebrospinal fluid (CSF) seeding. With
these radiologic features and tumor location, ependymoma
was considered the most likely diagnosis. Other tumors in
the differential, including schwannoma and metastasis,
were considered less likely.
A 70‑year‑old male (Case 2) with a history of multiple
tumors, including prostate cancer, colon cancer, gastric
cancer, and right arm schwannoma, presented with
worsening back pain. MRI of the lumbar spine showed
a 3.0 × 1.7 cm intradural extramedullary mass at T12‑L1,
displacing the spinal cord to the left. The lesion was
predominantly hypointense on T1, heterogeneously
hyperintense on T2 with a cystic area. The lesion
demonstrated heterogeneous enhancement [Figure 2].
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Figure 1: Case 1. 26-year-old male with low back pain diagnosed with Ewing’s
sarcoma/peripheral neuroectodermal tumor. (a) Magnetic resonance imaging
(MRI) sagittal T1 WI image shows a hypointense intradural mass lesion (solid
arrow) at the level of the conus medullaris (dashed arrow), (b) MRI Sagittal T2
WI image shows the lesion (solid arrow) to be mildly hyperintense, and (c) MRI
sagittal postcontrast T1 WI image shows the lesion (solid arrow) demonstrates
heterogeneous enhancement after administration of contrast. The conus cannot
be visualized separately from the lesion in all images (dashed arrows).
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Figure 2: Case 2. 70-year-old male with increasing back pain diagnosed
with Ewing’s sarcoma/peripheral neuroectodermal tumor. (a) Magnetic
resonance imaging (MRI) sagittal T1 WI image shows a hypointense intradural
extramedullary mass (arrow) at the level of T12-L1, (b) MRI Sagittal T2 WI
image shows a mixed signal intensity, predominantly hyperintense signal mass
with a cystic component (arrow), and (c) MRI sagittal postcontrast T1 WI image
demonstrates heterogeneous enhancement of the lesion (arrow).
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then the intramedullary portion of the tumor was gently
dissected off the rootlets with eventual resection of all
identified tumor. Intraoperative gross examination in Case
2 revealed a purple‑red lobulated mass. Due to extensive
entanglement of nerve roots in the tumor, the surgical
goal was to debulk as much of the mass as possible while
avoiding damage to peripheral nerve function.
Histologic examination of both tumors showed densely
packed sheets and nests of small cells with scant cytoplasm
and round to ovoid nuclei [Figure 3]. No microscopic features
of ependymoma, such as perivascular pseudorosettes or
ependymal rosettes, were identified in either case. Due to
the nonspecific small blue cell appearance of these tumors,
a series of immunohistochemical analyses was performed
in each case. The results and interpretation of the various
stains are shown in Table 1. The immunohistochemical
analysis ruled out lymphoma, Merkel cell carcinoma,
rhabdomyosarcoma, ependymoblastoma, neuroendocrine
carcinoma, Wilms’ tumor, germ cell tumor, and prostate
cancer. These findings, together with positive staining for
cluster of differentiation 99 (CD99) and Friend leukemia
integration 1 transcription factor (FLI‑1) in Case 1 and
positive staining for CD99 in Case 2, increased the likelihood
that these tumors were both ES/PNETs.
Over 90% of ES/PNETs have a chromosomal translocation
involving the Ewing’s sarcoma breakpoint region
1 (ESWR1). [5] Fluorescent in‑situ hybridization (FISH)
break‑apart assay for the EWSR1 gene rearrangement was
performed and revealed that both cases were positive
for this rearrangement, confirming the diagnosis of
ES/PNET [Figure 4]. In an attempt to identify a specific
translocation, both cases were tested using reverse
transcription polymerase chain reaction (RT‑PCR). No

Figure 3: Hematoxylin and eosin stained sections of tumors from both cases
(Case 2 shown here) show the classic histologic appearance of a small blue
cell neoplasm with nests of small round tumor cells with scanty cytoplasm.
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specific translocation was detected by the RT‑PCR assays
performed on the tumor in Case 1. The tumor in Case 2 was
positive for the presence of the Ewing sarcoma gene‑FLI1
gene (EWS‑FLI1) fusion transcript associated with ES/PNET.

DISCUSSION
ES/PNETs are aggressive, malignant neoplasms that
share histologic features with a number of other tumors.
Multimodality therapy with surgery, radiation therapy, and
chemotherapy has improved survival in ES/PNET from less
than 10% to up to 40%.[6] Immunohistochemical analysis of
small round cell tumors is crucial. In particular, CD99 and
FLI‑1 are useful in diagnosing ES/PNET, but these markers
can also be expressed in other tumors. CD99 shows diffuse
membranous positive staining in virtually all cases of ES/
PNET; however, CD99 expression is not specific for ES/PNET
because rhabdomyosarcomas, lymphoblastic lymphomas/
leukemias, synovial sarcomas, solitary fibrous tumors,
and neuroendocrine tumors may also demonstrate CD99
positivity.[7] Positive nuclear staining with FLI‑1 is also very
sensitive in the diagnosis of ES/PNET, but the FLI‑1 antibody
will also stain other tumor types, including vascular tumors
and lymphoblastic lymphoma. [8] Because positivity for
CD99 and/or FLI‑1 is suggestive of but not specific for ES/
PNET, it is necessary to include them in a comprehensive
panel of immunohistochemical markers that will help rule
out muscle, lymphoid, epithelial, germ cell, neuroglial, and
Merkel cell tumors.
Once ES/PNET is a top consideration in the pathologic
differential diagnosis, molecular studies are needed
as a complementary diagnostic tool. EWSR1 is one
of the most commonly involved genes in sarcoma

Figure 4: Fluorescent in situ hybridization for Ewing’s sarcoma breakpoint
region 1 (ESWR1) gene rearrangement performed reveals that the tumors in
both cases (Case 2 shown here) are positive for EWSR1 gene rearrangement
as indicated by the separation of red and green signals (arrows).
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Table 1: Immunohistochemical stain analysis of Case 1 and Case 2
Immunohistochemical stain

Cluster of differentiation 99
Friend leukemia integration 1
transcription factor
Cluster of differentiation 56
Neuron‑specific enolase
Synuclein
Cytokeratin pan‑cocktail AE1/AE3
Wilms’ tumor 1
Cytokeratin 20
Cluster of differentiation 45 and 20
Myogenic differentiation 1
Glial fibrillary acid protein
Placental alkaline phosphatase and
octamer‑binding transcription factor 4
Prostate‑specific antigen and prostate
acid phosphatase

Case 1

Case 2

+
+

+
Not performed

Not performed
+
+
+
–
–
–
–
–
–

+
–
Not performed
+
–
–
–
–
–
Not performed

Supports ES/PNET (sensitive but not specific)
Supports ES/PNET in context of other IHC results
in case 1
Supports neuroendocrine differentiation in case 2
Supports neuroendocrine differentiation in case 1
Supports neuroendocrine differentiation in case 1
Can be positive in ES/PNET
Rules out Wilms’ tumor
Rules out Merkel cell carcinoma
Rules out lymphoma
Rules out rhabdomyosarcoma
Rules out ependymoblastoma
Rules out germ cell neoplasm in case 1

Interpretation

Not performed

–

Rule out metastatic prostatic carcinoma in case 2

iHC: Immunohistochemistry, ES/PNET: Ewing’s sarcoma/peripheral neuroectodermal tumor

translocations. ES/PNETs are characterized by specific
chromosomal translocations, resulting in a fusion of
the EWSR1 gene (22q12) with one of the members of
the E26 transformation‑specific family of transcription
factors.[9] FISH break‑apart assay confirmed the presence
of a translocation involving EWSR1 in Case 1, but RT‑PCR
analysis did not detect which specific translocation
was present. Several reasons could account for this
discrepancy, including sensitivity of PCR to inadequate
tissue fixation or insufficient quantity of tumor specimen.
Additionally, the tumor from Case 1 may have an EWS‑FLI1
exon combination that produces a very long fusion
transcript not efficiently amplified from formalin‑fixed
paraffin‑embedded tissue. The patient in Case 2 was
70‑years‑old, an age group in which ES/PNETs are very
uncommon. However, this patient’s tumor was found to
harbor the EWS‑FLI1 translocation, the most common
translocation occurring in ES/PNETs. The final diagnosis
of ES/PNET in these two cases was made possible by a
combination of histological, immunohistochemical, and
molecular tests.
MRI is the investigation of choice for the evaluation of
lesions within the spinal canal. The tumors described here
are primary spinal extraosseous intradural ES/PNETs. On
complete imaging workup, there was no evidence of primary
lesions elsewhere, to suggest these lesions to be secondary.
Primary spinal ES/PNETs are extremely rare, slightly more
common in adults than in children and typically located
in the region of the filum terminale and cauda equina.
Myxopapillary ependymoma is the most common lesion
in the region of cauda equina and filum terminale and,
therefore, was considered the most likely diagnosis on
preoperative imaging. ES/PNET is typically hypointense on
T1, hyperintense on T2, and demonstrates heterogeneous
enhancement. When associated with hemorrhage, ES/
4

PNET can have hyperintense signal on T1. CSF seeding
may produce leptomeningeal enhancement.[10] However,
other more common masses including ependymoma,
schwannoma, and metastasis show similar imaging
findings, making it difficult to differentiate ES/PNET from
these lesions.[11] However, if imaging findings of a lesion in
the region of the filum terminale and cauda equina are not
classical for ependymoma or schwannoma, ES/PNET should
be considered, as treatment of this high grade neoplasm is
significantly different from the other benign lesions.

CONCLUSION
ES/PNET should be considered in the differential
diagnosis of intradural tumors of the spine, despite the
low frequency of their occurrence in this location. The
diagnostic workup should include imaging, histopathology,
immunohistochemical staining, and molecular analysis
including both FISH and RT‑PCR to identify and characterize
the EWSR1 translocation. All data should be considered as
a whole when characterizing small round blue cell tumors,
in order to arrive at the correct diagnosis and to assure
optimal therapy for the patient.
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